MENU
News
CME
Journals
All Specialties
All Specialties
Aesthetics
Allergy/Immunology
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
Infectious Disease
All Subspecialties
All Subspecialties
Antimicrobials
Dermatology
Emerging Diseases
Gastrointestinal Infections
Hepatitis C
HIV/AIDS
Influenza
MRSA
Nosocomial Infections
Pediatric ID
Practice Management
Respiratory Infections
STDs
Vaccination
Zoonotic Infections
More
Resources
Meeting News
Opinion
Meeting Calendar
Current Issues
Healio Jobs
Account
Log Out
Log In
News
Search
News
CME
Journals
Log In
Log Out
All Specialties
All Specialties
Aesthetics
Allergy/Immunology
Cardiac/Vascular Intervention
Cardiology
Dermatology
Endocrinology
Gastroenterology
Hematology/Oncology
Hepatology
Infectious Disease
Nephrology
Neurology
Ophthalmology
Optometry
Orthopedics
Pediatrics
Primary Care
Psychiatry
Pulmonology
Rheumatology
All Subspecialties
All Subspecialties
Antimicrobials
Dermatology
Emerging Diseases
Gastrointestinal Infections
Hepatitis C
HIV/AIDS
Influenza
MRSA
Nosocomial Infections
Pediatric ID
Practice Management
Respiratory Infections
STDs
Vaccination
Zoonotic Infections
Resources
Meeting News
Opinion
Meeting Calendar
Current Issues
Healio Jobs
Search
Healio
News
Infectious Disease
Current Issues
HCV Next Current Issue
Related Resources
About Us
Advertising Information
Contact the Editor
Editorial Policy and Philosophy
Meet the Editorial Board
Mission Statement
Order Article Reprints
Subscribe
Renew
Year
2018
2017
2016
2015
2014
Issue
January
February
March
April
May/June
July/August
September/October
November/December
View Issue
The following articles appeared in the print edition of
HCV Next
.
Table of Contents
Cost, Fear of Side Effects Key Barriers to HCV Treatment
Outpatient Endoscopy Offers Additional Chance for HCV Screening
HCV Timeline
Welcome to the New World Order: A Competitive HCV Drug Marketplace
Michael S. Saag, MD
Hospice Care May Come Too Late for Patients with Chronic Liver Disease
HBV Reactivation Uncommon in Patients Treated with DAA Therapies
HCV Clearance Lowers Liver Cancer Risk by 70% no Matter Drug of Choice
Primary Care Pharmacists Successfully Manage Uncomplicated HCV Cases
Surgeon General: We Will Conquer HCV, Opioids ‘One Bite at a Time’
Related Resources
About Us
Advertising Information
Contact the Editor
Editorial Policy and Philosophy
Meet the Editorial Board
Mission Statement
Order Article Reprints
Subscribe
Renew
